Company Comparison
Tango Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tango Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | South San Francisco, California |
| Founded | — | 2006 |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Tango Therapeutics
Tango Therapeutics develops precision oncology medicines using synthetic lethality approaches to target cancer vulnerabilities created by tumor suppressor gene loss.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Tango Therapeutics
Sector Overlap
Both Tango Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →